Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry aims to unlock secrets of cancer in older adults

NCT ID NCT01137825

Knowledge-focused Sponsor: UNC Lineberger Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This research study creates a registry of older adults with cancer to collect information about their health, treatments, and outcomes. Participants complete a geriatric assessment and allow researchers to follow their medical records. The goal is to better understand how cancer affects older people and to support future studies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could help researchers identify patterns that improve care and quality of life for older adults with cancer.
What could go wrong
This is an observational registry, not a treatment trial. It collects data but does not test any intervention, so direct benefits to participants are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 3,000 people

The number the study aims to enrol. It can still change while the study runs.

Start date

Sep 2009

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Oncology Patients or those with a presumed cancer diagnosis

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

DISEASE CHARACTERISTICS: * Patients must have an appointment at the North Carolina Cancer Hospital and agree to complete the Geriatric Assessment NOTE: Not all patients included in the registry will ultimately be diagnosed with cancer. Patients who complete a GA and are not diagnosed with cancer will remain in the database, but will be categorized into a separate group and will not have their medical records accessed. PATIENT CHARACTERISTICS: * Able to read and speak English PRIOR CONCURRENT THERAPY: * Not specified

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic myeloproliferative disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acquired polycythemia vera acute biphenotypic leukemia acute myeloid leukemia anaplastic large cell lymphoma angioimmunoblastic T-cell lymphoma B-cell chronic lymphocytic leukemia blast phase chronic myelogenous leukemia, BCR-ABL1 positive Burkitt lymphoma cancer chronic eosinophilic leukemia chronic myelomonocytic leukemia chronic neutrophilic leukemia Congenital Abnormalities diffuse large B-cell lymphoma essential thrombocythemia follicular lymphoma hairy cell leukemia Hodgkins lymphoma Immunoglobulin Light-chain Amyloidosis intraocular lymphoma large-cell immunoblastic lymphoma leukemia Leukemia, Large Granular Lymphocytic leukemia, myeloid, accelerated-phase Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Leukemia, Myeloid, Chronic-Phase lymphoma Lymphoma, B-Cell, Marginal Zone Lymphoma, Extranodal NK-T-Cell lymphoproliferative syndrome mantle cell lymphoma mast cell leukemia mycosis fungoides myelodysplastic syndrome Myelodysplastic Syndromes myelodysplastic/myeloproliferative disease myelodysplastic/myeloproliferative neoplasm Myeloproliferative Disorders myeloproliferative neoplasm non-Hodgkin lymphoma plasma cell myeloma plasma cell neoplasm Precursor Cell Lymphoblastic Leukemia-Lymphoma Precursor T-Cell Lymphoblastic Leukemia-Lymphoma primary cutaneous T-cell non-Hodgkin lymphoma primary myelofibrosis prolymphocytic leukemia Sezary syndrome Waldenstrom macroglobulinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic myeloproliferative disorders Cognitive/functional effects Leukemia Lymphoma Lymphoproliferative disorder Multiple myeloma and plasma cell neoplasm Myelodysplastic syndromes Myelodysplastic/myeloproliferative neoplasms Unspecified adult solid tumor, protocol specific

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Carolina East Radiology

    RECRUITING

    New Bern, North Carolina, 28560, United States

  • Carteret Health Care Cancer Center

    RECRUITING

    Morehead City, North Carolina, 28557, United States

  • East Carolina University

    RECRUITING

    Greenville, North Carolina, 27834, United States

  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill

    RECRUITING

    Chapel Hill, North Carolina, 27599-7295, United States

  • Pardee Cancer Center

    RECRUITING

    Hendersonville, North Carolina, 28739, United States

  • Rex Healthcare

    RECRUITING

    Raleigh, North Carolina, 27607, United States

  • Seby B. Jones Cancer Center

    RECRUITING

    Boone, North Carolina, 28607, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.